Skip to main content
  1. Life
  2. Relationships
  3. Relationship Advice

Race for female viagra continues, filbanserin makers ignore HSDD controversy

See also

The race for an HSDD drug continues, even though the disease may be an attempt to pathologize asexuality. A recent study shows that increased serotonin improves arousal and desire in post-menopausal women. Hypoactive Sexual Desire Disorder remains controversial, but the pharmaceutical companies press forward despite the controversy. Asexual groups attempted to get the American Psythciatric Association to significantly alter the definition, and one psychiatrist described the disorder as being tailor-made for the pharmaceutical industry.

Researchers at George Washington University conducted a double-blind study on the filbanserin, a proposed HSDD drug. The test group received 100 milligrams of the proposed drug, while the control group received a placebo. Test group participants who did not suffer from depression or other psychiatric issues showed an improvement in sexual function and desire, according to Helio.com. The double-blind study Participants were not asked about their sexual orientation.

Drug companies want to win the race to create a female Viagra. They do not worry about the legitimacy of the condition. The DSM-V task force split HSDD into two disorders in the current edition of the psychiatric manual. Asexuals view these disorders classify their orientation as an illness, and members of Asexuality Visibility and Education network met with the DSM-V task force to discuss their concerns. Gays and lesbians faced a similar problem until the early 1970s, when the American Psychological Association removed homosexuality from its guidebook. A psychiatrist can only diagnose someone with the disorder if their lack of desire for sex causes the patient distress.

Some of the proposed drugs do not target all age groups. Instead, they target post-menopausal women who wish to boost their libido. Testosterone levels drop as people get older. The hormone controls sex drive in members of both sexes. Other drug companies attempt an across-the-board treatment, despite the low cure rates for hypoactive sexual desire disorder.

Advertisement

Life

  • Dan Savage
    Dan Savage cares about LGBT youth, bullying and saving lives
    Today's Buzz
  • Raku
    Teachers and students can use this summer to learn a new skill
    Camera
    15 Photos
  • Beach body
    Fitness: Earn your beach body badge with bootcamp classes
    Camera
    10 Photos
  • Greek wine
    Unwind with these delicious wines: The thrilling wines of Greece
    Camera
    7 Photos
  • Mandy Moore
    Exclusive interview with Celebrity Mandy Moore concerning animal activism
    Camera
    5 Photos
  • Educational family vacations
    Find out how to take an educational family vacation that doesn't break the bank
    Camera
    9 Photos

Related Videos: